lumasiran

Italy

Drugs containing this active substance

  • OXLUMO

    It is used for the treatment of primary hyperoxaluria type 1 (PH1) in adults and children of all ages. This rare disease causes an excess of oxalate in the liver, which can accumulate in the kidneys and damage other organs such as the heart, bones, skin, and eyes.

    Form: solution for injection

    Active substance Dosage
    lumasiran -

    ATC: A16AX18

    Manufacturer: ALNYLAM NETHERLANDS BV